G. Caleb Alexander

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

75h-index23.4kcitations503works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Opioid Use Disorder Treatment(89), Health Systems, Economic Evaluations, Quality of Life(86), Pharmaceutical Practices and Patient Outcomes(82), Pharmaceutical Economics and Policy(73), Medication Adherence and Compliance(55)

Publications502 total

Introducing advanced ClearIQ engine (AiCE) deep learning reconstruction algorithm into a clinical radiotherapy workflow
British Journal of Radiology·2025
Weight Changes From Glucagon‐Like Peptide‐1 Receptor Agonist Use and Discontinuation: A Retrospective Cohort Study
Obesity·2025Open Access
OIDA-QA: A Multimodal Benchmark for Analyzing the Opioid Industry Documents Archive
arXiv (Cornell University)·2025Open Access
Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study
PLoS Medicine·2025· 1 citedOpen Access
Revisiting the FDA’s Accelerated Approval Pathway
JAMA·2025
The Value of Sensitivity Analyses in Assessing the Risk of Two Rare Neurological Adverse Events and Pseudoephedrine Use
Drug Safety·2025Open Access
Research and development investments for biologics independently developed by US biotechnology startups, 2017–2023
Health Affairs Scholar·2025Open Access
US Public Health Gains from Improved Treatment of Hypercholesterolemia: A Simulation Study of NHANES Adults Treated to Guideline-Directed Therapy
Journal of General Internal Medicine·2025· 1 citedOpen Access
Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV: Erratum
AIDS·2025
Assessing US Food and Drug Administration Guidance Practices in Drug Development
JAMA Health Forum·2025Open Access
Medicare Part D Preferred Pharmacy Networks And The Risk For Pharmacy Closure, 2014–23
Health Affairs·2025Open Access
Interventions to improve patient safety during the COVID-19 pandemic: a systematic review
BMJ Open Quality·2025· 1 citedOpen Access
Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C.
UNC Libraries·2025Open Access
Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C
PLoS Medicine·2025· 4 citedOpen Access
Use of Statins for Primary Prevention Among Individuals With CKD in the United States: A Cross-Sectional, Time-Trend Analysis
American Journal of Kidney Diseases·2024· 7 cited
An audit of the impact of the introduction of a commercial artificial intelligence-driven auto-contouring tool into a radiotherapy department
British Journal of Radiology·2024· 6 citedOpen Access
More US Pharmacies Closed Than Opened In 2018–21; Independent Pharmacies, Those In Black, Latinx Communities Most At Risk
Health Affairs·2024· 23 cited
Abstract 4123530: Disparities in Hypertension Treatment Intensification among Adults in a Large United States Healthcare System
Circulation·2024
Hospital-Level Variation in COVID-19 Treatment Among Hospitalized Adults in the United States
Medical Care·2024Open Access
Accelerated approvals: Early-phase success or premature authorization?
Cancer Cell·2024· 4 cited
page 1 of 26Next →

Frequent Co-authors

Hsien‐Yen Chang(8), Dima M. Qato(6), Randall S. Stafford(6), Sonal Singh(5), Matthew Daubresse(5), Jocelyn Wilder(3), Eleanor Lucas(3), James Heyward(3), Nilay D. Shah(3), Lainie Rutkow(3), Catherine S. Hwang(2), Rena M. Conti(2), L. Philip Schumm(2), Stacy Tessler Lindau(2), Mark C. Bicket(2), Omar Mansour(2), Neena S. Abraham(2), William H. Crown(2), Stefan Kruszewski(2), Elizabeth A. Stuart(2)